“Doctor, what else can I do for my glaucoma?” Exercise, nicotinamide and other lifestyle interventions

Clinical & Experimental OphthalmologyVolume 51, Issue 4 p. 289-290 EDITORIAL "Doctor, what else can I do for my glaucoma?" Exercise, nicotinamide and other lifestyle interventions Jonathan G. Crowston MBBS, PhD, Corresponding Author Jonathan G. Crowston MBBS, PhD [email protected] Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia Neuroscience and Behavioural Diseases and Eye-ACP, Duke-NUS, Singapore Singapore Eye Research Institute and Singapore National Eye Centre, Singapore Correspondence Jonathan G. Crowston, Save Sight Institute, University of Sydney, Sydney, NSW, Australia. Email: [email protected]Search for more papers by this authorVicki Chrysostomou PhD, Vicki Chrysostomou PhD Neuroscience and Behavioural Diseases and Eye-ACP, Duke-NUS, Singapore Singapore Eye Research Institute and Singapore National Eye Centre, SingaporeSearch for more papers by this authorKatharina C. Bell MD, PhD, Katharina C. Bell MD, PhD Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia Neuroscience and Behavioural Diseases and Eye-ACP, Duke-NUS, Singapore Singapore Eye Research Institute and Singapore National Eye Centre, SingaporeSearch for more papers by this author Jonathan G. Crowston MBBS, PhD, Corresponding Author Jonathan G. Crowston MBBS, PhD [email protected] Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia Neuroscience and Behavioural Diseases and Eye-ACP, Duke-NUS, Singapore Singapore Eye Research Institute and Singapore National Eye Centre, Singapore Correspondence Jonathan G. Crowston, Save Sight Institute, University of Sydney, Sydney, NSW, Australia. Email: [email protected]Search for more papers by this authorVicki Chrysostomou PhD, Vicki Chrysostomou PhD Neuroscience and Behavioural Diseases and Eye-ACP, Duke-NUS, Singapore Singapore Eye Research Institute and Singapore National Eye Centre, SingaporeSearch for more papers by this authorKatharina C. Bell MD, PhD, Katharina C. Bell MD, PhD Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia Neuroscience and Behavioural Diseases and Eye-ACP, Duke-NUS, Singapore Singapore Eye Research Institute and Singapore National Eye Centre, SingaporeSearch for more papers by this author First published: 14 June 2023 https://doi.org/10.1111/ceo.14241Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. CONFLICT OF INTEREST STATEMENT The authors declare that there is no conflict of interest. REFERENCES 1Kumar A, Ou Y. From bench to behavior: the role of lifestyle factors on intraocular pressure, neuroprotection, and disease progression in glaucoma. Clin Exp Ophthalmol. 2023; 54(4): 380-394. 10.1111/ceo.14218 Google Scholar 2Williams PA, Harder JM, John SWM. Glaucoma as a metabolic optic neuropathy: making the case for nicotinamide treatment in glaucoma. J Glaucoma. 2017; 26(12): 1161-1168. 10.1097/IJG.0000000000000767 PubMedWeb of Science®Google Scholar 3Tribble JR, Otmani A, Sun S, et al. Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction. Redox Biol. 2021; 43:101988. 10.1016/j.redox.2021.101988 CASPubMedWeb of Science®Google Scholar 4Hui F, Tang J, Williams PA, et al. Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: a crossover randomized clinical trial. Clin Exp Ophthalmol. 2020; 48(7): 903-914. 10.1111/ceo.13818 PubMedWeb of Science®Google Scholar 5De Moraes CG, John SWM, Williams PA, et al. Nicotinamide and pyruvate for neuroenhancement in open-angle glaucoma: a phase 2 randomized clinical trial. JAMA Ophthalmol. 2022; 140(1): 11-18. 10.1001/jamaophthalmol.2021.4576 PubMedWeb of Science®Google Scholar 6Tang J, Hui F, Hadoux X, et al. Short-term changes in the photopic negative response following intraocular pressure lowering in glaucoma. Invest Ophthalmol Vis Sci. 2020; 61(10): 16. 10.1167/iovs.61.10.16 PubMedWeb of Science®Google Scholar 7Kim J, Aschard H, Kang JH, et al. Intraocular pressure, glaucoma, and dietary caffeine consumption: a gene-diet interaction study from the UK Biobank. Ophthalmology. 2021; 128(6): 866-876. 10.1016/j.ophtha.2020.12.009 PubMedWeb of Science®Google Scholar 8Sehi M, Grewal DS, Goodkin ML, Greenfield DS. Reversal of retinal ganglion cell dysfunction after surgical reduction of intraocular pressure. Ophthalmology. 2010; 117(12): 2329-2336. 10.1016/j.ophtha.2010.08.049 PubMedWeb of Science®Google Scholar 9Caprioli J, de Leon JM, Azarbod P, et al. Trabeculectomy can improve long-term visual function in glaucoma. Ophthalmology. 2016; 123(1): 117-128. 10.1016/j.ophtha.2015.09.027 PubMedWeb of Science®Google Scholar 10Spaeth GL. The effect of change in intraocular pressure on the natural history of glaucoma: lowering intraocular pressure in glaucoma can result in improvement of visual fields. Trans Ophthalmol Soc U K (1962). 1985; 104(Pt 3): 256-264. PubMedWeb of Science®Google Scholar 11Crowston JG, Kong YXG, Trounce IA, et al. An acute intraocular pressure challenge to assess retinal ganglion cell injury and recovery in the mouse. Exp Eye Res. 2015; 141: 3-8. 10.1016/j.exer.2015.03.006 CASPubMedWeb of Science®Google Scholar 12Weinreb RN, Liebmann JM, Cioffi GA, et al. Oral memantine for the treatment of glaucoma: design and results of 2 randomized, placebo-controlled, phase 3 studies. Ophthalmology. 2018; 125(12): 1874-1885. 10.1016/j.ophtha.2018.06.017 PubMedWeb of Science®Google Scholar 13Ramulu PY, Maul E, Hochberg C, Chan ES, Ferrucci L, Friedman DS. Real-world assessment of physical activity in glaucoma using an accelerometer. Ophthalmology. 2012; 119(6): 1159-1166. 10.1016/j.ophtha.2012.01.013 PubMedWeb of Science®Google Scholar Volume51, Issue4May/June 2023Pages 289-290 ReferencesRelatedInformation